Omeprazol y clopidogrel asociado a trombosis de stent

Omeprazol y clopidogrel asociado a trombosis de stent

El clopidogrel es un fármaco empleado en la prevención de complicaciones aterotrombóticas en pacientes que han sufrido infarto de miocardio, así como en terapia combinada con el ácido acetilsalicílico en pacientes que les será colocado stent tras angioplastia transluminar percutánea, por lo cual deb...

Full description

Bibliographic Details
Main Authors:	Ricardo Amador García Hernández, Lianet Rivero Seriel
Format:	Article
Language:	Spanish
Published:	Editorial Ciencias Médicas
Series:	Revista Cubana de Medicina
Subjects:	clopidogrel omeprazol drug interaction stent thrombosis
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232013000200008&lng=en&tlng=en

Similar Items

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática Clinical relevance of clopidogrel and omeprazole interaction: systematic review
by: Héctor Holguín, et al.
Published: (2012-01-01)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
by: Kenngott S, et al.
Published: (2010-05-01)

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática
by: Héctor Holguín, QF, et al.
Published: (2012-01-01)

Cost-effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2021-01-01)

Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
by: Hamid Reza Poorhosseini, et al.
Published: (2012-04-01)

Effectiveness of Two-Year Versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
by: Ali Reza Amirzadegan, et al.
Published: (2012-06-01)

Comparação entre a ranitidina e o omeprazol em relação a possíveis interações medicamentosas com o clopidogrel em pacientes portadores de doenças arterial coronária estável
by: Remo Holanda de Mendonça Furtado
Published: (2015)

Comparação entre a ranitidina e o omeprazol em relação a possíveis interações medicamentosas com o clopidogrel em pacientes portadores de doenças arterial coronária estável
by: Furtado, Remo Holanda de Mendonça
Published: (2015)

SUB-ACUTE STENT THROMBOSIS AND IN-STENT RESTENOSIS ASSOCIATED WITH ANTIPLATELETS CLOPIDOGREL RESISTANCE AND PROTEIN S DEFICIENCY
by: M Zakky Kurniawan, et al.
Published: (2016-11-01)

Clopidogrel resistance: The way forward
by: Shuvanan Ray
Published: (2014-09-01)

Predictors of premature clopidogrel discontinuation within 30 days of successful coronary artery stenting
by: Çayan Cakir, et al.
Published: (2018-01-01)

THE PROTOCOL: INFLUENCE OF THE COMBINATION CARRIAGE СУР2С19*2 AND *17 ON EFFICACY OF CLOPIDOGREL
by: Е. М. Zelenskaya, et al.
Published: (2017-11-01)

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
by: Berger Peter B
Published: (2000-10-01)

Efecto de la interacción clopidogrel-omeprazol en el reingreso hospitalario de pacientes por recidiva de síndrome coronario agudo: estudio de casos y controles
by: Pedro Amariles, et al.
Published: (2014-10-01)

Evaluation of clopidogrel response with light transmission aggregometry before extra- intracranial stenting
by: D.V. Shchehlov, et al.
Published: (2020-01-01)

Very late stent trombosis. An unpleasant surprise.
by: César Enrique Filgueiras Frías, et al.
Published: (2011-01-01)

Obesity, leptin, and thrombosis: Focus on clopidogrel resistance
by: Bilgehan Karadağ
Published: (2016-10-01)

Importance of pharmacogenetics for therapeutic use of clopidogrel
by: Rančić Nemanja, et al.
Published: (2013-01-01)

Trombosis muy tardía en stent metálico convencional. Reporte de un caso. Very late thrombosis related to conventional metallic stent: A case report.
by: Rogelio Pérez Collado, et al.
Published: (2010-01-01)

Incidencia de trombosis de stents coronarios en el «mundo real» Incidence of coronary stent thrombosis in the «real world»
by: Bernardo Lombo, et al.
Published: (2010-06-01)

Pharmacogenomic Testing and Antithrombotic Therapy: Ready for Prime Time?
by: David R. Holmes, Jr.
Published: (2013-01-01)

Evaluación económica del tratamiento con ácido acetilsalicílico más esomeprazol comparado con clopidogrel en la prevención de la hemorragia gastrointestinal Economic evaluation of the treatment of aspirin plus esomeprazole compared to clopidogrel in gastrointestinal bleeding prevention
by: Carme Piñol
Published: (2006-02-01)

Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura following Endovascular Treatment of Spontaneous Carotid Artery Dissection
by: Jerry A. Rubano, et al.
Published: (2015-10-01)

S-omeprazol : Självständigt arbete i kemiteknik med läkemedelsinriktning
by: Billinger, Erika, et al.
Published: (2010)

High-residual platelet activity despite dual antiplatelet treatment associated with subacute stent thrombosis
by: Malý Martin, et al.
Published: (2009-03-01)

Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study
by: Xiao-Fei Gao, et al.
Published: (2018-05-01)

Stent thrombosis: Prevention and management
by: Rajendra Kumar Jain, et al.
Published: (2014-01-01)

Late and Very Late Stent Thrombosis in the Era of Second Generation Drug Eluding Stents
by: Jaya Mallidi, et al.
Published: (2016-08-01)

Analyzing the Effect of Comorbidities and Drug Usage in Clopidogrel Unresponsive Patients
by: Eda Kılıç Çoban, et al.
Published: (2015-08-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Omeprazol sódico
by: Murakami, Fábio Seigi
Published: (2012)

Prescripción, dispensación y sustitución de recetas de omeprazol Prescription, dispensation and sustitution of prescription forms of omeprazole
by: M. B. Vaquero
Published: (2003-07-01)

Influence of methadone on clopidogrel in addicts on methadone maintenance therapy
by: Ferigol Fallah, et al.
Published: (2016-04-01)

Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity
by: Chen Ning, et al.
Published: (2021-09-01)

Variabilité de réponse au clopidogrel : bases biologiques, mécanismes, conséquences cliniques et alternatives thérapeutiques
by: Cuisset, Thomas
Published: (2010)

The anti ulcer effect of omeprazole is modified by Nigella sativa (Black Cumin) in ethanol induced gastric ulceration in rabbits
by: Jawad Ahmed, et al.
Published: (2020-12-01)

Die konventionelle Plättchenaggregometrie unterschätzt das unzureichende Ansprechen auf Clopidogrel bei KHK-Patienten im Vergleich zu einem P2Y12-spezifischen Test
by: Weinberger, Sarah
Published: (2010)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
by: Iida Hiroshi, et al.
Published: (2012-03-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Clopidogrel-statin interaction: A missing links
by: Todorović Zoran M., et al.
Published: (2016-01-01)